Healthy Living/WellnessLilly's Type 2 diabetes drug trials halted by the FDA The FDA has denied an application for approval of Type 2 diabetes drug empagliflozin, citing quality control standards at the manufacturing plant. The drug is been produced by Eli Lilly and Co and Boehringer Ingelheim.by Tabitha Laffernis
Healthy Living/WellnessFDA allows Plan B generic morning-after pills to be sold OTC without age restrictionsby Rhodilee Jean Dolor
Healthy Living/WellnessWhy FDA-approved Zohydro painkiller may be a bad idea after allby Maryanne Moll
Healthy Living/WellnessTestosterone drug should carry warning of heart risk, consumer group saysby Pierre Dumont
Healthy Living/WellnessProposal for revamped nutrition labels unveiled by the FDA and Michelle Obamaby Tabitha Laffernis
Healthy Living/WellnessFDA mulls giving green light to controversial 3-person embryo fertilization techniqueby Alex Saltarin
Healthy Living/Wellness3-person embryo technique, mitochondrial replacement, scrutinized by the FDAby Tabitha Laffernis
Healthy Living/WellnessE-cigarette lobbyists face uphill battle against FDA regulationsby Maryanne Moll
Healthy Living/WellnessFDA bans US sale of 4 bidis...which weren't being sold for years, anywaysby Maryanne Moll